Li-Xuan Qin, Ph.D. - Publications

2005 University of Washington, Seattle, Seattle, WA 
Biostatistics Biology, Public Health, Statistics

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Qin LX, Tuschl T, Singer S. Empirical insights into the stochasticity of small RNA sequencing. Scientific Reports. 6: 24061. PMID 27052356 DOI: 10.1038/srep24061  0.6
2016 Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer S. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma. Annals of Surgical Oncology. PMID 26759307 DOI: 10.1245/s10434-015-5063-5  0.32
2015 Huang HC, Niu Y, Qin LX. Differential Expression Analysis for RNA-Seq: An Overview of Statistical Methods and Computational Software. Cancer Informatics. 14: 57-67. PMID 26688660 DOI: 10.4137/CIN.S21631  0.6
2015 Crago AM, Chmielecki J, Rosenberg M, O'Connor R, Byrne C, Wilder FG, Thorn K, Agius P, Kuk D, Socci ND, Qin LX, Meyerson M, Hameed M, Singer S. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes, Chromosomes & Cancer. PMID 26171757 DOI: 10.1002/gcc.22272  0.6
2015 Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015: 532478. PMID 26074722 DOI: 10.1155/2015/532478  0.6
2015 Kelly KJ, Yoon SS, Kuk D, Qin LX, Dukleska K, Chang KK, Chen YL, Delaney TF, Brennan MF, Singer S. Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma: A Retrospective 2-Institution Study. Annals of Surgery. 262: 156-62. PMID 26061213 DOI: 10.1097/SLA.0000000000001063  0.32
2015 Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, Moraco N, Crago AM, Singer S. Histology-Based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Annals of Surgery. PMID 25915910 DOI: 10.1097/SLA.0000000000001149  0.32
2015 Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, Brogi E, Viale A, Morrow M, Reis-Filho JS, King TA. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Molecular Oncology. 9: 772-82. PMID 25601220 DOI: 10.1016/j.molonc.2014.12.005  0.6
2015 Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunology Research. 3: 380-8. PMID 25600439 DOI: 10.1158/2326-6066.CIR-14-0212  0.6
2015 D'Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, Dickson MA, Gounder M, Keohan ML, Schwartz GK, Tap WD. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Human Pathology. 46: 357-65. PMID 25540867 DOI: 10.1016/j.humpath.2014.11.001  0.6
2014 Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, Tap WD, Fletcher JA, Huberman KH, Qin LX, Viale A, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nature Genetics. 46: 1227-32. PMID 25240281 DOI: 10.1038/ng.3095  0.32
2014 Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, Crago AM, Alektiar KM. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3236-41. PMID 25185087 DOI: 10.1200/JCO.2013.53.9452  0.6
2014 Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nature Genetics. 46: 595-600. PMID 24793135 DOI: 10.1038/ng.2969  0.32
2014 Qin LX, Breeden L, Self SG. Finding gene clusters for a replicated time course study. Bmc Research Notes. 7: 60. PMID 24460656 DOI: 10.1186/1756-0500-7-60  0.32
2013 Qin LX, Tuschl T, Singer S. An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study. Cancer Informatics. 12: 83-101. PMID 23589668 DOI: 10.4137/CIN.S11384  0.6
2013 Schwartz GK, Tap WD, Qin LX, Livingston MB, Undevia SD, Chmielowski B, Agulnik M, Schuetze SM, Reed DR, Okuno SH, Ludwig JA, Keedy V, Rietschel P, Kraft AS, Adkins D, et al. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. The Lancet. Oncology. 14: 371-82. PMID 23477833 DOI: 10.1016/S1470-2045(13)70049-4  0.6
2012 Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, Jia X, Qin LX, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, O'Reilly EM, Allen PJ. A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. Plos One. 7: e40157. PMID 22792233 DOI: 10.1371/journal.pone.0040157  0.6
2012 Crago AM, Socci ND, DeCarolis P, O'Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1334-40. PMID 22241790 DOI: 10.1158/1078-0432.CCR-11-2820  0.6
2012 Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, Qin LX, Arroyo CD, Brogi E, Morrow M, King TA. Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Research and Treatment. 132: 641-52. PMID 22080244 DOI: 10.1007/s10549-011-1860-0  0.6
2012 Morrogh M, Andrade VP, Patil AJ, Qin LX, Mo Q, Sakr R, Arroyo CD, Brogi E, Morrow M, King TA. Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole. The Journal of Surgical Research. 176: 121-32. PMID 21777924 DOI: 10.1016/j.jss.2011.05.058  0.6
2011 Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecologic Oncology. 121: 444-50. PMID 21354599 DOI: 10.1016/j.ygyno.2011.01.025  0.6
2009 Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5240-7. PMID 19770384 DOI: 10.1200/JCO.2008.20.0386  0.6
2009 Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, ... ... Qin LX, et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3133-40. PMID 19451436 DOI: 10.1200/JCO.2008.20.4495  0.6
2009 Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Research. 69: 573-82. PMID 19147571 DOI: 10.1158/0008-5472.CAN-08-2088  0.6
2006 Qin LX, Self SG. The clustering of regression models method with applications in gene expression data. Biometrics. 62: 526-33. PMID 16918917 DOI: 10.1111/j.1541-0420.2005.00498.x  0.6
2006 Qin LX, Beyer RP, Hudson FN, Linford NJ, Morris DE, Kerr KF. Evaluation of methods for oligonucleotide array data via quantitative real-time PCR. Bmc Bioinformatics. 7: 23. PMID 16417622 DOI: 10.1186/1471-2105-7-23  0.6
2005 Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, Cunningham ML, Deng S, Dressman HK, Fannin RD, Farin FM, ... ... Qin LX, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nature Methods. 2: 351-6. PMID 15846362 DOI: 10.1038/nmeth754  0.6
2004 Qin LX, Kerr KF. Empirical evaluation of data transformations and ranking statistics for microarray analysis. Nucleic Acids Research. 32: 5471-9. PMID 15479783 DOI: 10.1093/nar/gkh866  0.6
Show low-probability matches.